CORALAB
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Coral Laboratories do?
Coral Laboratories Ltd operates in the pharmaceutical industry with a strong focus on quality control. They offer a wide range of products including capsules, tablets, liquids, ointments, injections, and more.
Who are the competitors of Coral Laboratories?
Coral Laboratories major competitors are Kimia Biosciences, Alpa Lab, Murae Organisor, Krebs Biochem.&Inds, Panchsheel Organics, Ambalal Sarabhai Ent, Vaidya Sane Ayur Lab. Market Cap of Coral Laboratories is ₹219 Crs. While the median market cap of its peers are ₹208 Crs.
Is Coral Laboratories financially stable compared to its competitors?
Coral Laboratories seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Coral Laboratories pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Coral Laboratories latest dividend payout ratio is 4.53% and 3yr average dividend payout ratio is 4.53%
How has Coral Laboratories allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Coral Laboratories balance sheet?
Balance sheet of Coral Laboratories is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Coral Laboratories improving?
Yes, profit is increasing. The profit of Coral Laboratories is ₹24.16 Crs for TTM, ₹15.79 Crs for Mar 2024 and ₹6.45 Crs for Mar 2023.
Is the debt of Coral Laboratories increasing or decreasing?
Yes, The net debt of Coral Laboratories is increasing. Latest net debt of Coral Laboratories is -₹76.31 Crs as of Mar-25. This is greater than Mar-24 when it was -₹122.38 Crs.
Is Coral Laboratories stock expensive?
Coral Laboratories is not expensive. Latest PE of Coral Laboratories is 9.07, while 3 year average PE is 12.36. Also latest EV/EBITDA of Coral Laboratories is 5.44 while 3yr average is 10.13.
Has the share price of Coral Laboratories grown faster than its competition?
Coral Laboratories has given better returns compared to its competitors. Coral Laboratories has grown at ~35.11% over the last 3yrs while peers have grown at a median rate of -4.85%
Is the promoter bullish about Coral Laboratories?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Coral Laboratories is 71.51% and last quarter promoter holding is 71.51%.
Are mutual funds buying/selling Coral Laboratories?
There is Insufficient data to gauge this.